Reported 2 days ago
Chemed Corporation has updated its earnings forecast for 2025 after reporting a 9.8% year-on-year revenue growth of $646.9 million in Q1. However, the company anticipates lower earnings for Q2, prompting analysts from Bank of America and RBC Capital to reduce their stock price targets, while still maintaining a positive outlook on the shares. Chemed operates in the healthcare and essential home services sectors through its subsidiaries VITAS Healthcare and Roto-Rooter.
Source: YAHOO